This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

HMS Holdings Management Discusses Q2 2012 Results - Earnings Call Transcript

During this call, the company will also be referring to several non-GAAP measures. The press release issued this morning includes a reconciliation of these measures to GAAP measures and is available on the Investor Relations tab of the company's website.

Thank you. Mr. Lucia, you may begin your conference.

William C. Lucia

Thank you, Katherine, and good morning, everyone. Thank you for joining our second quarter 2012 earnings call. I'm Bill Lucia, President and CEO of HMS Holdings. I'll be hosting the call, along with Walter Hosp, our CFO.

HMS had another strong quarter. Revenue was up 34.4% to $120.1 million compared to $89.3 million for the same period a year ago. Adjusted EPS grew 35% year-over-year to $0.23 per share. The backdrop for our call today is the Supreme Court decision to uphold the constitutionality of the ACA, providing clear support for HMS' long-term growth strategy. This ruling has removed many of the uncertainties related to the ACA, and many states are now moving forward with the law, including the Medicaid Recovery Audit Contractor program. I'll talk more about this later.

Walter will now review our financials and then I will discuss our sales and the Supreme Court ruling and its impact on HMS' growth strategy. Walter?

Walter D. Hosp

Thank you, Bill. Good morning, everyone. As Bill mentioned, revenue for the second quarter of 2012 increased 34.4% year-over-year due to $120.1 million. This nearly matches the $121.2 million consensus forecast of security analysts who follow HMS.

Revenue growth in the quarter was mixed across our markets. In our Medicaid market, which includes State Government and Medicaid managed care clients, year-over-year revenue growth was 12.2% for the quarter. In our federal business, we previously announced our decision to not rebid one CMS audit MIC contract. We also spoke of specific Medicare ZPIC contracts that we terminated due to conflicts with HDI's Medicare RAC contract. As a result of these decisions, revenues in our federal business was down 14.9% year-over-year. HDI revenues for the quarter were $23.8 million to go. Because HDI was not part of HMS in the second quarter of 2011, there is no comparable growth rate. However, we would estimate that HDI's year-over-year organic growth for the quarter is approximately 90% after adjusting for differences in revenue recognition. We are also reaffirming the 2012 revenue guidance for HDI at approximately $95 million.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs